Live News Categoriesequity

Akeso, Inc. (9926.HK) News

Track canonical SquawkNews coverage tagged to 9926.HK, Akeso, Inc.. This hub brings together deduplicated headlines about mainland china, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol 9926.HK Asset equity Sector Markets 90 days 1 Last 98 Updated Sep 21, 2026, 11:47 PM UTC Open live news feed

M Akeso flags Phase III overall survival data for ivonescimab in biliary tract cancer Akeso said it has positive overall survival results from a Phase III study of ivonescimab in first-line advanced biliary tract cancer. The company has not yet presented the data and said they are scheduled as a late-brea EARNINGS | Sep 21, 2026, 11:47 PM UTC